---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-22-019486"
form_type: "8-K"
ticker: null
cik: "0000008868"
company_name: "AVON PRODUCTS INC"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-22T00:26:05.350280+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Avon Products approves closure of Suffern R&D facility, relocation to Brazil and Poland with $39M restructuring costs

## Summary
- Board approved plan to close Suffern, NY R&D facility and relocate to Brazil and Poland by end of June 2024 fiscal quarter.
- Expected non-recurring restructuring costs of approximately $39.0 million and capital expenditures of $10.0 million.
- Potential impairment charge on fixed assets in the range of $35.0 million to $40.0 million.
- Relocation aims to deliver Global Innovation Program and realize cost efficiencies.

## SEC filing metadata
- accession: 0000950103-22-019486
- form_type: 8-K
- cik: 0000008868
- company_name: AVON PRODUCTS INC
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05, 2.06, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/8868/000095010322019486/0000950103-22-019486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/8868/000095010322019486/dp184155_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-22-019486
- JSON: https://secwatch.observer/filing/0000950103-22-019486.json
- Plain text: https://secwatch.observer/filing/0000950103-22-019486.txt

## Key facts
- Restructurings & Charges
  AVON PRODUCTS INC announced a impairment with charges of $35.0 million to $40.0 million affecting fixed assets related to Suffern facility closure.
  - Type: impairment
  - Charge: $35.0 million to $40.0 million
  - Affected area: fixed assets related to Suffern facility closure
  source text: Avon is also performing an impairment analysis over fixed assets and, as a result, expects to record a potential impairment charge in the range of $35.0 million to $40.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/8868/000095010322019486/0000950103-22-019486-index.htm
- Restructurings & Charges
  AVON PRODUCTS INC announced a restructuring with charges of approximately $39.0 million affecting research and development facilities in Suffern, New York, relocated to Brazil and Poland.
  - Type: restructuring
  - Charge: approximately $39.0 million
  - Affected area: research and development facilities in Suffern, New York, relocated to Brazil and Poland
  source text: development activities to Brazil and Poland. Avon expects to incur non-recurring restructuring costs in connection with the closure and relocation in the amount of approximately $39.0 million, to be incurred in the fiscal years ending December 31, 2022, 2023, 2024 and 2025 and capital expenditures relating to the infrastructure and facilities in Brazil and Poland
  evidence_url: https://www.sec.gov/Archives/edgar/data/8868/000095010322019486/0000950103-22-019486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.